The U.S. Centers for Disease Control (CDC) carefully monitors measles cases nationwide through mandatory reporting systems. As of late April 2026, the question of whether cumulative U.S. measles cases will reach 1850 by month's end depends on knowing both the current case count and daily transmission trajectory. Measles outbreaks typically follow school term calendars and vaccination coverage patterns, clustering in geographic areas with lower immunization rates. The current YES odds of just 2% suggest traders assess a surge of that magnitude within four days as highly improbable. To resolve YES, the total U.S. measles case count would need to reach or exceed 1850 by April 30, 2026 at 00:00 UTC. The low probability pricing implies either the cumulative count is already well below that threshold with minimal daily additions, or vaccination coverage and public health response measures in recent months have maintained transmission control. Historical measles resurgence periods—including the 2019 outbreak and regional clusters in following years—saw gradual case increases over weeks or months rather than explosive four-day jumps. The market's pricing reflects standard epidemiological mechanics.
Deep dive — what moves this market
Measles remains a disease of public health significance in the United States despite high national vaccination coverage, which typically hovers around 90-95 percent for the two-dose childhood regimen. The epidemiology of measles in the U.S. has evolved significantly over the past two decades, with most contemporary cases linked to international importation or occurring in clusters within pockets of lower vaccination coverage. The most significant recent outbreak occurred in 2019, when 1,276 cases were reported nationwide—the highest annual total in over a decade. That outbreak, concentrated in New York City and surrounding areas, developed over the course of several months and was driven by importation into highly susceptible populations with lower MMR uptake. Even during that major surge, reaching 1,276 cases took sustained transmission across a year. The CDC's measles surveillance system captures cases through mandatory national reporting, with healthcare providers required to report suspected and confirmed cases to state health departments. This reporting network, while occasionally experiencing lag periods of days to weeks for administrative processing, provides reliable cumulative tallies. For this market to resolve YES, either a major outbreak would need to be actively spreading with hundreds of cases per day—which would be extraordinarily visible in public health communications—or the current case count would already be within striking distance of 1850 with only moderate additional cases needed. Measles typically has a 10-14 day incubation period, and cases require confirmed diagnosis plus reporting, both introducing significant lag in the reporting cycle. Vaccination resistance varies regionally, with some areas concentrated in specific states, but national analysis suggests measles transmission potential remains limited due to geographic distribution of immunity and swift public health response mechanisms. The current 2% market odds reflect the structural difficulty of accumulating 1850 cases in four days without an already-active massive outbreak well-documented and widely reported through official channels. Traders have essentially concluded the probabilistic path to 1850 by month's end is exceptionally narrow, likely requiring either a cascade event or evidence of pre-existing large-scale transmission already in progress.
